Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

The outcomes for patients with metastatic or locally recurrent Epstein–Barr virus (EBV)-positive nasopharyngeal carcinoma (NPC) remain poor. Adoptive immunotherapy with EBV-specific cytotoxic T lymphocytes (EBV-CTLs) has proven clinical efficacy, but it has never been evaluated in the first-line tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chia, Whay-Kuang, Teo, Marissa, Wang, Who-Whong, Lee, Bernett, Ang, Soo-Fan, Tai, Wai-Meng, Chee, Chit-Lai, Ng, Joanna, Kan, Rebecca, Lim, Wan-Teck, Tan, Sze-Huey, Ong, Whee-Sze, Cheung, Yin-Bun, Tan, Eng-Huat, Connolly, John E, Gottschalk, Stephen, Toh, Han-Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978790/
https://www.ncbi.nlm.nih.gov/pubmed/24297049
http://dx.doi.org/10.1038/mt.2013.242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978790/
https://www.ncbi.nlm.nih.gov/pubmed/24297049
http://dx.doi.org/10.1038/mt.2013.242

Ejemplares similares